Beam Therapeutics Inc. Common Stock Share Price
NASDAQ: BEAMHealthcare
Live Beam Therapeutics Inc. Common Stock Share Price Chart
O H L
Beam Therapeutics Inc. Common Stock Performance Overview
Days Range
▼
$24.16Low
$25.45High
Markets Today
| Previous Close | $23.10 |
|---|---|
| Open | $24.44 |
| Volume | 1,281,066 |
| Day's Range | $24.16 - $25.45 |
| 52W Range | $0.00 - $0.00 |
| Market Cap | $2.40 B |
Historical Performance
| 1M Returns | -14.76 |
|---|---|
| 3M Returns | -28.88 |
| 6M Returns | -10.57 |
| 1Y Returns | +2.90 |
| 5Y Returns | -77.55 |
| 10Y Returns | NA |
Beam Therapeutics Inc. Common Stock Fundamentals
| Market Cap | $2.40 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $139.74 M |
| ROE TTM | -0.08 |
| EPS TTM | $0.00 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.25 |
| EBITDA | $-361.40 M |
| Profit Margin | -57.24 |
| Market Cap | $2.40 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $139.74 M |
| ROE TTM | -0.08 |
| EPS TTM | $0.00 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.25 |
| EBITDA | $-361.40 M |
| Profit Margin | -57.24 |
Beam Therapeutics Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $7.47 M | $8.47 M | $9.70 M | $114.11 M | $31.74 M | $490.00 K |
| Gross Profit + | $7.47 M | $8.47 M | $9.70 M | $114.11 M | $31.74 M | $490.00 K |
| Operating Income | -$119.29 M | -$120.18 M | -$126.81 M | -$17.45 M | -$107.22 M | -$126.76 M |
| EBITDA | -$113.76 M | -$114.64 M | -$121.25 M | -$11.78 M | -$101.61 M | -$121.35 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $5.53 M | $5.54 M | $5.56 M | $5.67 M | $5.61 M | $5.41 M |
| Income Before Tax | -$108.33 M | -$102.14 M | -$112.73 M | $244.30 M | -$94.32 M | -$122.68 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$108.33 M | -$102.14 M | -$112.73 M | $244.30 M | -$94.32 M | -$122.68 M |
| Net Profit Margin | -1450.2% | -1206.45% | -1162.38% | 214.09% | -297.18% | -25036.33% |
Beam Therapeutics Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.01 M | $1.01 M | $1.01 M | $1.02 M | $1.03 M | $1.03 M |
| Reserve & Surplus | -$1.68 B | -$1.78 B | -$1.89 B | -$1.64 B | -$1.74 B | -$1.86 B |
| Non-Current Liabilities | $202.24 M | $170.21 M | $162.52 M | $145.88 M | $241.79 M | $238.03 M |
| Current Liabilities | $141.55 M | $174.13 M | $182.56 M | $96.94 M | $74.56 M | $80.88 M |
| Total Liabilities | $343.78 M | $344.34 M | $345.08 M | $242.82 M | $316.36 M | $318.91 M |
| Fixed Assets | $109.57 M | $108.82 M | $108.29 M | $104.50 M | $101.25 M | $97.61 M |
| Current Assets | $1.25 B | $1.18 B | $1.10 B | $1.27 B | $1.27 B | $1.18 B |
| Total Assets | $1.47 B | $1.39 B | $1.31 B | $1.48 B | $1.48 B | $1.39 B |
Beam Therapeutics Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$108.33 M | -$102.14 M | -$112.73 M | $244.30 M | -$94.32 M | -$122.68 M |
| Operating Cash Flow | -$103.88 M | -$76.45 M | -$81.48 M | -$83.29 M | -$128.51 M | -$66.10 M |
| Investing Cash Flow | -$125.09 M | -$170.41 M | $65.66 M | $108.41 M | $25.27 M | -$9.88 M |
| Financing Cash Flow | $473.38 M | $1.11 M | $1.68 M | $1.89 M | $96.61 M | $7.52 M |
| Change in Cash | $244.41 M | -$245.75 M | -$14.15 M | $27.00 M | -$6.64 M | -$68.45 M |
Beam Therapeutics Inc. Common Stock Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $1.59B | -92.70% | 0.00 | -609.85% | 0.00% |
 | $5.01B | -58.07% | 0.00 | -16569.77% | 0.00% |
 | $403.92M | -95.71% | 0.00 | -395.01% | 0.00% |
| $5.01B | -58.07% | 0.00 | -16569.77% | 0.00% |
| $1.59B | -92.70% | 0.00 | -609.85% | 0.00% |
 | $3.26B | -62.03% | 0.00 | NA | 0.00% |
 | $569.52M | NA | 0.00 | -4342.44% | 0.00% |
| $403.92M | -95.71% | 0.00 | -395.01% | 0.00% |
Beam Therapeutics Inc. Common Stock Return Calculator
The Beam Therapeutics Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,384
Invested Amount$10,000
Est. Returns$-7,616
About Beam Therapeutics Inc. Common Stock
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.
Popular Stocks
FAQs
What is the share price of Beam Therapeutics Inc. Common Stock today?
Beam Therapeutics Inc. Common Stock (BEAM) share price as of September 17, 2026 is $24.53. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Beam Therapeutics Inc. Common Stock?
Yes, Indian Investors can invest in the Beam Therapeutics Inc. Common Stock (BEAM) Share by opening an international trading account with Angel One.
How can I purchase Beam Therapeutics Inc. Common Stock shares in India?
Purchasing Beam Therapeutics Inc. Common Stock (BEAM) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Beam Therapeutics Inc. Common Stock (BEAM) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Beam Therapeutics Inc. Common Stock?
Yes, you can purchase fractional shares of Beam Therapeutics Inc. Common Stock (BEAM) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Beam Therapeutics Inc. Common Stock?
The market capitalization of Beam Therapeutics Inc. Common Stock on September 17, 2026, is $2.40 B.
In which sector Beam Therapeutics Inc. Common Stock belongs?
Beam Therapeutics Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Beam Therapeutics Inc. Common Stock stocks?
In order to invest in Beam Therapeutics Inc. Common Stock (BEAM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
